Ampersand Lays Out Regulatory Path For Alternatives To Traditional Pap
This article was originally published in The Gray Sheet
Executive Summary
Ampersand Medical plans to submit a 510(k) with supporting clinical data late this summer for the company's e2 Collector cervical cell collection device.